Obstructive Sleep Apnea-Hypopnea Syndrome in a Patient with Severe Psychopathology

被引:1
|
作者
Konstantinou, Gerasimos N. [1 ]
Vlachos, Themistocles K. [1 ]
Stogioglou, Dimitrios G. [1 ]
Vasilopoulou, Polyxeni P. [1 ]
机构
[1] 251 Hellen Air Force Gen Hosp, Dept Psychiat, Athens, Greece
关键词
D O I
10.3928/00485713-20200627-01
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
A 46-year-old man with severe obesity (body mass index [BMI] of 52 kg/m2) was admitted for hospitalization in the psychiatric department of a general hospital because of behavioral disorders and constant suicidal and homicidal ideation. The patient had posted a threatening message on a social media network about his manager at work after a conflict between them, stating that he had “a specific plan to harm either himself or his manager.” Initial evaluation included a semi-structured diagnostic interview by a clinical psychiatrist, the Hamilton Depression Scale-21 items test (HAMD-21) (score of 27), the Hamilton Anxiety Scale (HAM-A) (score of 26), the Montreal Cognitive Assessment (MoCA) (score of 22), and the Brief Psychiatric Rating Scale (BPRS) (score of 96). At the time of the initial psychiatric assessment, the patient presented with poor insight and judgment. He was confused, irritated, suspicious, and incapable of describing his feelings. He had a remarkable dysfunction in emotional awareness, social attachment, and interpersonal relating (all of which are core characteristics of alexithymia). The patient's colleagues who accompanied him to the hospital reported that the patient presented with high levels of anxiety, psychomotor agitation, social withdrawal, poor personal hygiene, and constant suicidal and homicidal ideation in the last 20 days before his admission, and that the symptoms had been gradually worsening. Laboratory test results revealed moderate liver damage and hyperlipidemia, with a serum aspartate aminotransferase level of 47 U/L (normal range, 13-30 U/L), total cholesterol level of 267 mg/dL (normal range <200 mg/dL), and triglyceride level of 258 mg/dL (normal range, 40–150 mg/dL). He had remarkably high blood pressure (210/130 mm Hg). Drug test results were negative, and magnetic resonance imaging showed no pathological signs. He had been diagnosed previously with hypertension and had a history of two previous hospitalizations in a psychiatric department because of depressive symptoms and suicidal ideation. In the past, he had refused any medication for hypertension or for the psychiatric symptoms. Six years ago, he had also been diagnosed with alopecia areata related to high levels of anxiety. © SLACK Incorporated.
引用
收藏
页码:365 / 368
页数:4
相关论文
共 50 条
  • [41] Sleep oxygen desaturation and circulating leptin in obstructive sleep apnea-hypopnea syndrome
    Tatsumi, K
    Kasahara, Y
    Kurosu, K
    Tanabe, N
    Takiguchi, Y
    Kuriyama, T
    [J]. CHEST, 2005, 127 (03) : 716 - 721
  • [42] Biomarkers of Alzheimer's disease in severe obstructive sleep apnea-hypopnea syndrome in the Chinese population
    Kong, Weili
    Zheng, Yun
    Xu, Wei
    Gu, Hailing
    Wu, Junhao
    [J]. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2021, 278 (03) : 865 - 872
  • [43] Sleep Apnea-Hypopnea Syndrome in the Elderly
    Angel Martinez-Garcia, Miguel
    Duran-Cantolla, Joaquin
    Maria Montserrat, Jose
    [J]. ARCHIVOS DE BRONCONEUMOLOGIA, 2010, 46 (09): : 479 - 488
  • [44] Obstructive sleep apnea-hypopnea syndrome and comorbidities: a retrospective Moroccan study
    Achrane, J.
    Jniene, A.
    Harrak, L.
    Achachi, L.
    El Ftouh, M.
    [J]. JOURNAL OF SLEEP RESEARCH, 2018, 27
  • [45] Corneal Endothelial Morphology and Thickness Alterations in Patients With Severe Obstructive Sleep Apnea-Hypopnea Syndrome
    Chalkiadaki, Evangelia
    Andreanos, Konstantinos
    Florou, Chrysoula
    Droutsas, Konstantinos
    Maniou, Chrysoula
    Amfilochiou, Anastasia
    Georgalas, Ilias
    Papaconstantinou, Dimitrios
    Koutsandrea, Chrysanthi
    [J]. CORNEA, 2021, 40 (01) : 73 - 77
  • [46] Implication of mixed sleep apnea events in adult patients with obstructive sleep apnea-hypopnea syndrome
    Yang, Xiuping
    Xiao, Ying
    Han, Baoai
    Lin, Kun
    Niu, Xun
    Chen, Xiong
    [J]. SLEEP AND BREATHING, 2019, 23 (02) : 559 - 565
  • [47] The effect of obstructive sleep apnea-hypopnea syndrome on acute myocardial infarction
    Zhang, W.
    Sun, Y.
    Li, T.
    Zhang, G.
    Wang, Y.
    Sun, H.
    [J]. BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2012, 113 (09): : 565 - 568
  • [48] Obstructive sleep apnea-hypopnea syndrome in children: Beyond adenotonsillar hypertrophy
    Estetier, Eduard
    [J]. ACTA OTORRINOLARINGOLOGICA ESPANOLA, 2015, 66 (02): : 111 - 119
  • [49] Biomarkers and Dynamic Cerebral Autoregulation of Obstructive Sleep Apnea-Hypopnea Syndrome
    Zhang, Yanan
    Wu, Xiaodan
    Sun, Qingqing
    Tang, Qi
    Guo, Zhen-Ni
    Wang, Zan
    Yang, Yi
    [J]. NATURE AND SCIENCE OF SLEEP, 2021, 13 : 2019 - 2028
  • [50] Plasma orexin-A levels in obstructive sleep apnea-hypopnea syndrome
    Igarashi, N
    Tatsumi, K
    Nakamura, A
    Sakao, S
    Takiguchi, Y
    Nishikawa, T
    Kuriyama, T
    [J]. CHEST, 2003, 124 (04) : 1381 - 1385